ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 781–792 of 2020 project topics
dCas9-Based DNA Methylation Editing
Engineering dCas9 fused to DNA methyltransferase and demethylase domains for targeted CpG methylation editing at specific genomic loci for epigenetic disease therapy research.
Epigenome Editing Biotechnology Click to view more details →
Wilson Disease ATP7B Variant Characterization
Characterizing ATP7B pathogenic variants causing Wilson disease for molecular diagnosis and correlating with neurological versus hepatic disease presentation.
Genetic Basis of Liver Disease Click to view more details →
Hemochromatosis HFE and Non-HFE Genetics
Developing testing strategies for C282Y, H63D, and non-HFE hemochromatosis genes TFR2, HJV, and HAMP for comprehensive hereditary hemochromatosis diagnosis.
Genetic Basis of Liver Disease Click to view more details →
Histone Modification Editing for Gene Activation
Developing dCas9-based histone acetyltransferase fusion proteins for targeted H3K27 acetylation and gene activation at silenced therapeutic gene loci in disease cell models.
Epigenome Editing Biotechnology Click to view more details →
Bile Acid Synthesis Disorder Gene Testing
Applying bile acid disorder gene panels for identifying AKR1D1, CYP7A1, and other enzyme defects causing cholestatic liver disease in children.
Genetic Basis of Liver Disease Click to view more details →
Epigenome Wide Association Study Methodology
Designing and analyzing EWAS studies linking differential DNA methylation patterns with disease phenotypes in human population cohorts for epigenetic biomarker discovery.
Epigenome Editing Biotechnology Click to view more details →
NAFLD Genetic Susceptibility Variant Analysis
Characterizing PNPLA3, TM6SF2, and MBOAT7 variants contributing to NAFLD severity and progression for patient risk stratification.
Genetic Basis of Liver Disease Click to view more details →
Therapeutic Epigenome Reprogramming Strategies
Developing epigenome reprogramming approaches using small molecule epigenetic drugs and targeted editing tools for reversing pathological epigenetic states in cancer and neurological disease.
Epigenome Editing Biotechnology Click to view more details →
Alpha-1 Antitrypsin Deficiency Diagnostic Panel SaaS
A cloud-based diagnostic platform that sequences and interprets SERPINA1 variants to identify AAT deficiency subtypes with automated phenotyping algorithms. This platform enables laboratory networks and healthcare systems to rapidly scale AAT testing capacity while generating recurring subscription revenue through per-sample analysis fees.
Genetic Basis of Liver Disease Click to view more details →
Prime Editor Delivery Systems for Clinical Gene Correction
Commercial delivery platforms optimize prime editor mRNA and protein packaging into lipid nanoparticles and viral vectors for in vivo epigenome editing applications. This enables pharmaceutical companies to develop precision medicines targeting heritable epigenetic diseases with reduced off-target effects and improved therapeutic efficacy.
Epigenome Editing Biotechnology Click to view more details →
AI-Powered Epigenome Prediction SaaS for Drug Discovery
Cloud-based machine learning platforms predict epigenetic changes and cellular responses to editing interventions across genomic regions in real-time. Biotech and pharma clients reduce development timelines by 40-60% and accelerate lead candidate identification for epigenetic disease therapeutics.
Epigenome Editing Biotechnology Click to view more details →
Progressive Familial Intrahepatic Cholestasis Gene Variant Classifier
A machine learning-powered tool that categorizes PFIC-causing mutations across ATP8B1, ABCB11, and ABCB4 genes with clinical severity predictions. Laboratories can license this classifier on a tiered model, generating revenue from both one-time implementations and ongoing data licensing agreements with pharmaceutical research firms.
Genetic Basis of Liver Disease Click to view more details →